|
시장보고서
상품코드
1535251
일시적 단백질 발현 시장 : 시장 규모 및 예측, 지역별 점유율, 동향, 성장 기회 분석 보고서 - 제품 유형별, 용도별, 최종사용자별, 지역별Transient Protein Expression Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Application, End User, and Geography |
||||||
일시적 단백질 발현 시장 규모는 2023년 8억 3,668만 달러에서 2031년에는 13억 2,038만 달러에 달할 것으로 예측됩니다. 이 시장은 2023-2031년 사이 5.9%의 CAGR을 기록할 것으로 예상됩니다. 단백질 발현 워크플로우에 인공지능(AI)과 자동화 기술을 통합하여 전체 프로세스의 효율성, 정확성 및 확장성을 향상시키기 위해 정밀 의료 분야에서의 적용을 포함한 단백질 발현 시스템의 적용 범위 확대가 시장의 주요 트렌드가 될 것으로 보입니다.
일시적 단백질 발현 시장의 시장 촉진요인
단백질 발현 시스템의 적용 범위 확대
동물 및 식물 세포 기반 일시적 단백질 발현 시스템은 지난 30 년 동안 사용되어 왔습니다. 최근 단백질체학의 눈부신 발전으로 더 많은 새로운 재조합 단백질 품종을 사용할 수 있게 되었습니다. 동물 및 식물 세포에서 일시적 단백질 발현의 실용성과 재현성은 인간 세포주로의 응용을 확대하는 연구 개발 활동을 촉진하고 있습니다. 많은 연구 개발 위탁 기관과 바이오 제약 회사 등이 일시적 단백질 발현을 생산 공정에 통합하는 데 주력하고 있습니다. 이러한 발현 시스템은 안정적인 세포주 개발에 의존하지 않고도 다양한 유전자를 사용하여 재조합 단백질을 생산할 수 있게 해줍니다.
일시적 단백질 발현 공정은 성장 인자, 사이토카인, 호르몬, 혈액 제제, 변형된 인간 단백질, 단클론항체 생산에 널리 응용되고 있습니다. 또한, 효과적인 바이오 공정 기술의 창조와 사용은 중요한 치료 가치를 지닌 재조합 단백질의 상업적 합성에 필수적입니다. 바이오프로세스 분야의 최근 동향은 재조합 단백질을 생산하기 위한 효율적인 방법을 제공하기 위해 적용되고 있습니다. 현대적인 품질에 의한 설계 개념, 연속적인 업스트림 공정, 연속 크로마토그래피, 통합된 연속 바이오프로세스, 효율적인 바이오프로세스 최적화를 위한 고처리 장비, 일회용 시스템, 고품질 제품을 더 높은 수율로 얻을 수 있는 공정 분석 기술 등 등이 일시적 단백질 발현 시스템의 채택을 촉진하는 최근 트렌드 중 하나입니다.
신흥국에서 치료용 단백질 생산을 위한 식물 기반 발현 시스템이 시장 기회를 창출
미생물 또는 포유류 세포를 기반으로 한 발현 시스템의 사용은 재조합 단백질 생산 공정에서 일반적인 관행이었지만, 최근 몇 년 동안 식물 기반 발현은 비용 효율적이고 확장 가능하며 안전하고 지속가능한 대안으로 추진되고 있습니다. 일시적 발현법의 발전으로 식물 기반 발현 시스템에서 단백질 합성 기간이 크게 단축되어 재조합 단백질의 수율이 향상되었습니다. 소비자의 식물 유래 제품에 대한 선호도 변화로 인해 제약회사와 바이오 제약회사는 치료용 단백질의 식물 유래 합성에 주목하고 있습니다. 식물의 활용은 인간과 동물의 질병을 예방하거나 치료하기 위해 투여할 수 있는 단백질의 수율을 향상시킬 수 있는 잠재력을 가지고 있습니다. 치료용 단백질의 사용은 규제 프레임워크의 재구축과 식물의 일시적 단백질 발현에 대한 인식이 높아짐에 따라 향후 몇 년 동안 헬스케어 분야에서 급성장할 것으로 예상됩니다. 최대 규모화 가능성, 낮은 증식 비용, 복잡한 단백질 생산능력, 낮은 오염(특히 인간 병원체 포함) 위험, 최적화된 증식 조건 등은 식물에서 일시적 단백질 발현을 수행하는 것과 관련된 주요 이점 중 하나입니다. 또한, 식물은 내독소를 생성하지 않고 인체에 해를 끼치지 않기 때문에 다른 발현 시스템에 비해 안전하다고 여겨집니다. 따라서, 치료용 단백질 발현을 위한 식물 기반 발현 시스템은 예측 기간 동안 일시적 단백질 발현 시장의 성장을 위한 중요한 기회로 부상하고 있습니다.
일시적 단백질 발현 시장 부문별 개요
일시적 단백질 발현 시장의 분석에 기여한 주요 부문은 제품 유형, 용도 및 최종사용자입니다.
제품 유형에 따라 일시적 단백질 발현 시장은 기기, 시약, 발현 벡터, 유능한 세포로 구분되며, 2023년에는 기기 부문이 가장 큰 시장 점유율을 차지했습니다.
용도별로는 유전체 연구, 유전자 치료, 생물 생산, 암 연구, 의약품 개발로 구분되며, 2023년에는 유전체 연구 분야가 가장 큰 점유율을 차지했습니다.
최종사용자별로 보면 일시적 단백질 발현 시장은 제약 및 생명공학 기업, 학술 및 연구 기관, 임상 연구 기관으로 구분되며, 2023년에는 제약 및 생명공학 기업 부문이 시장을 장악했습니다.
일시적 단백질 발현 시장의 지리적 개요
일시적 단백질 발현 시장의 조사 범위는 주로 북미, 아시아태평양, 유럽, 중동 및 아프리카, 중남미 등 5개 지역으로 나뉩니다. 북미는 2023년 시장을 장악했습니다. 북미 일시적 단백질 발현 시장은 미국, 캐나다, 멕시코를 기준으로 분석됩니다. 매출액 기준으로 북미는 2023년 가장 큰 시장 점유율을 차지했습니다. 미국은 일시적 단백질 발현 절차 및 시스템에 있어 세계에서 가장 중요한 시장입니다. 미국 시장 성장의 배경에는 바이오 제약 산업의 광범위한 R&D 활동, 단백질 발현 관련 스타트업의 증가, 치료용 재조합 단백질의 채택 증가 등이 있습니다. 또한, 미국에서 사업을 전개하는 다양한 시장 리더들의 존재는 일시적 단백질 발현 시장 규모 확대에 크게 기여하고 있습니다.
목차
제1장 소개
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제 요인 분석
- 기초 수치 작성
- 데이터 삼각측량
- 국가 레벨 데이터
제4장 일시적 단백질 발현 시장 상황
- PEST 분석
제5장 일시적 단백질 발현 시장 : 주요 시장 역학
- 일시적 단백질 발현 시장 - 주요 시장 역학
- 시장 성장 촉진요인
- 단백질 발현 시스템 용도 확대
- 정밀의료 급증
- 시장 성장 억제요인
- 높은 제품 비용
- 시장 기회
- 치료용 단백질 생산을 위한 식물 기반 발현 시스템
- 향후 동향
- 인공지능(AI)과 자동화 기술의 통합
- 성장 촉진요인과 억제요인의 영향
제6장 일시적 단백질 발현 시장 : 세계 시장 분석
- 일시적 단백질 발현 시장 매출, 2021-2031년
- 일시적 단백질 발현 시장 예측 분석
제7장 일시적 단백질 발현 시장 분석 : 제품 유형별
- 기기
- 시약
- 발현 벡터
- 컴피턴트 세포
제8장 일시적 단백질 발현 시장 분석 : 용도별
- 유전체 연구
- 유전자 치료
- 바이오 생산
- 암 연구
- 의약품 개발
제9장 일시적 단백질 발현 시장 분석 : 최종사용자별
- 제약·바이오테크놀러지 기업
- 학술·연구기관
- 임상 연구기관
제10장 일시적 단백질 발현 시장 : 지역별 분석
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
- 중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트
- 기타 중동 및 아프리카
제11장 경쟁 상황
- 기업 포지셔닝과 집중도
제12장 업계 상황
- 일시적 단백질 발현 시장의 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
- 성장 전략
제13장 기업 개요
- Thermo Fisher Scientific Inc
- Merck KGaA
- QIAGEN NV
- GenScript Biotech Corporation
- Promega Corp
- Takara Bio Inc
- New England Biolabs
- Agilent Technologies Inc
- Mirus Bio LLC
- Bio-Rad Laboratories Inc
- Lonza Group AG
- MaxCyte Inc
제14장 부록
ksm 24.09.20The transient protein expression market size is projected to reach US$ 1,320.38 million by 2031 from US$ 836.68 million in 2023. The market is expected to register a CAGR of 5.9% during 2023-2031. Expanded application range of protein expression systems, including applications in the field of precision medicine, owing to the integration of artificial intelligence (AI) and automation technologies in protein expression workflows to enhance the efficiency, accuracy, and scalability of the overall process is likely to remain a key trend in the market.
Market Drivers of the Transient Protein Expression Market
Increasing Applications of Protein Expression Systems
Animal and plant cell-based transient protein expression systems have been in use for the last three decades. Significant advancements in proteomics in recent years have resulted in the availability of newer recombinant protein varieties. The practicality and reproducibility of transient protein expression in animal and plant cells encourage research and development activities to extend their applications in human cell lines. Many contract research and development organizations as well as biopharmaceutical companies, among others, have focused their efforts on incorporating transient protein expression into their production processes. This type of expression system allows them to use different genes to create recombinant proteins without relying on the development of stable cell lines.
The temporary protein expression process finds widespread application in the manufacturing of growth factors, cytokines, hormones, blood products, modified human proteins, and monoclonal antibodies. Moreover, the creation and use of effective bioprocessing techniques have become essential for the commercial synthesis of recombinant proteins with significant therapeutic value. Recent developments in the field of bioprocessing are being applied to provide efficient methods for generating recombinant proteins. Modern Quality by Design concepts, continuous upstream processing, continuous chromatography, integrated continuous bioprocessing, high-throughput devices for efficient bioprocess optimization, disposable systems, and process analytics technologies for higher yields of high-quality products are among the recent developments that propel the adoption of transient protein expression systems.
Plant-Based Expression Systems for Therapeutic Protein Production in Emerging Countries to Create Market Opportunities
The use of microbial or mammalian cell-based expression systems has been a common practice in recombinant protein production processes; however, plant-based expression has been promoted as a cost-effective, scalable, safe, and sustainable alternative in recent years. Advancements in transient expression methods have resulted in a significantly shortened duration of protein synthesis and the improved yield of recombinant proteins in plant-based systems. A shift in consumer preference toward plant-based products compels pharmaceutical and biopharmaceutical companies to focus on plant-based synthesis of therapeutic proteins. The use of plants has excellent potential for improving yields of proteins that can be administered for the prevention or treatment of human and animal diseases. The use of therapeutic proteins is likely to surge in the healthcare sector in the coming years due to the ongoing restructuring of regulatory frameworks and growing awareness about transient protein expression in plants. Maximum scale-up possibility, low growth costs, complex protein production ability, low contamination (especially involving human pathogens) risks, and optimized growth conditions are among the key advantages associated with carrying out transient protein expression in plants. Moreover, plants are considered safer compared to other expression systems as they do not produce endotoxins and cause less harm to humans. Thus, plant-based expression systems for therapeutic protein expression are emerging as vital opportunities for the transient protein expression market growth during the forecast period.
Transient Protein Expression Market: Segmental Overview
Key segments that contributed to the derivation of the transient protein expression market analysis are product type, application, and end user.
Based on product type, the transient protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The instruments segment held the largest market share in 2023.
By application, the market is segmented into genomic research, gene therapy, bioproduction, cancer research, and drug development. The genomic research segment accounted for the largest share of the market in 2023.
Based on end user, the transient protein expression market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment dominated the market in 2023.
Transient Protein Expression Market: Geographical Overview
The geographic scope of the transient protein expression market report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America dominated the market in 2023. The North America transient protein expression market has been analyzed on the basis of the US, Canada, and Mexico. In terms of revenue, North America accounted for the largest market share in 2023. The US is the world's most important market for transient protein expression procedures and systems. The market growth in the country is attributed to extensive research and development activities in the biopharmaceuticals industry, a growing number of startups involved in protein expression, and the rising adoption of recombinant protein for therapeutic applications. In addition, the presence of various market leaders operating in the US contributes notably to the expansion of the transient protein expression market size.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Transient Protein Expression Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
5. Transient Protein Expression Market - Key Market Dynamics
- 5.1 Transient Protein Expression Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Increasing Applications of Protein Expression Systems
- 5.2.2 Surging Popularity of Precision Medicine
- 5.3 Market Restraints
- 5.3.1 High Cost of Products
- 5.4 Market Opportunities
- 5.4.1 Plant-Based Expression Systems for Therapeutic Protein Production
- 5.5 Future Trends
- 5.5.1 Integration of Artificial Intelligence (AI) and Automation Technologies
- 5.6 Impact of Drivers and Restraints:
6. Transient Protein Expression Market - Global Market Analysis
- 6.1 Transient Protein Expression Market Revenue (US$ Million), 2021-2031
- 6.2 Transient Protein Expression Market Forecast Analysis
7. Transient Protein Expression Market Analysis - by Product Type
- 7.1 Instruments
- 7.1.1 Overview
- 7.1.2 Instruments: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Reagents
- 7.2.1 Overview
- 7.2.2 Reagents: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 7.3 Expression Vectors
- 7.3.1 Overview
- 7.3.2 Expression Vectors: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 7.4 Competent Cells
- 7.4.1 Overview
- 7.4.2 Competent Cells: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
8. Transient Protein Expression Market Analysis - by Application
- 8.1 Genomic Research
- 8.1.1 Overview
- 8.1.2 Genomic Research: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 8.2 Gene Therapy
- 8.2.1 Overview
- 8.2.2 Gene Therapy: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 8.3 Bio production
- 8.3.1 Overview
- 8.3.2 Bio production: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 8.4 Cancer Research
- 8.4.1 Overview
- 8.4.2 Cancer Research: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 8.5 Drug Development
- 8.5.1 Overview
- 8.5.2 Drug Development: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
9. Transient Protein Expression Market Analysis - by End User
- 9.1 Pharmaceutical and Biotechnology Companies
- 9.1.1 Overview
- 9.1.2 Pharmaceutical and Biotechnology Companies: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2 Academic and Research Institutes
- 9.2.1 Overview
- 9.2.2 Academic and Research Institutes: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3 Clinical Research Organizations
- 9.3.1 Overview
- 9.3.2 Clinical Research Organizations: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
10. Transient Protein Expression Market - Geographical Analysis
- 10.1 Overview
- 10.2 North America
- 10.2.1 North America Transient Protein Expression Market Overview
- 10.2.2 North America: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.3 North America: Transient Protein Expression Market Breakdown, by Product Type
- 10.2.3.1 North America: Transient Protein Expression Market - Revenue and Forecast Analysis - by Product Type
- 10.2.4 North America: Transient Protein Expression Market Breakdown, by Application
- 10.2.4.1 North America: Transient Protein Expression Market - Revenue and Forecast Analysis - by Application
- 10.2.5 North America: Transient Protein Expression Market Breakdown, by End User
- 10.2.5.1 North America: Transient Protein Expression Market - Revenue and Forecast Analysis - by End User
- 10.2.6 North America: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.2.6.1 North America: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.2.6.2 United States: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.6.2.1 United States: Transient Protein Expression Market Breakdown, by Product Type
- 10.2.6.2.2 United States: Transient Protein Expression Market Breakdown, by Application
- 10.2.6.2.3 United States: Transient Protein Expression Market Breakdown, by End User
- 10.2.6.3 Canada: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.6.3.1 Canada: Transient Protein Expression Market Breakdown, by Product Type
- 10.2.6.3.2 Canada: Transient Protein Expression Market Breakdown, by Application
- 10.2.6.3.3 Canada: Transient Protein Expression Market Breakdown, by End User
- 10.2.6.4 Mexico: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.2.6.4.1 Mexico: Transient Protein Expression Market Breakdown, by Product Type
- 10.2.6.4.2 Mexico: Transient Protein Expression Market Breakdown, by Application
- 10.2.6.4.3 Mexico: Transient Protein Expression Market Breakdown, by End User
- 10.3 Europe
- 10.3.1 Europe Transient Protein Expression Market Overview
- 10.3.2 Europe: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.3 Europe: Transient Protein Expression Market Breakdown, by Product Type
- 10.3.3.1 Europe: Transient Protein Expression Market - Revenue and Forecast Analysis - by Product Type
- 10.3.4 Europe: Transient Protein Expression Market Breakdown, by Application
- 10.3.4.1 Europe: Transient Protein Expression Market - Revenue and Forecast Analysis - by Application
- 10.3.5 Europe: Transient Protein Expression Market Breakdown, by End User
- 10.3.5.1 Europe: Transient Protein Expression Market - Revenue and Forecast Analysis - by End User
- 10.3.6 Europe: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.3.6.1 Europe: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.3.6.2 Germany: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.2.1 Germany: Transient Protein Expression Market Breakdown, by Product Type
- 10.3.6.2.2 Germany: Transient Protein Expression Market Breakdown, by Application
- 10.3.6.2.3 Germany: Transient Protein Expression Market Breakdown, by End User
- 10.3.6.3 United Kingdom: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.3.1 United Kingdom: Transient Protein Expression Market Breakdown, by Product Type
- 10.3.6.3.2 United Kingdom: Transient Protein Expression Market Breakdown, by Application
- 10.3.6.3.3 United Kingdom: Transient Protein Expression Market Breakdown, by End User
- 10.3.6.4 France: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.4.1 France: Transient Protein Expression Market Breakdown, by Product Type
- 10.3.6.4.2 France: Transient Protein Expression Market Breakdown, by Application
- 10.3.6.4.3 France: Transient Protein Expression Market Breakdown, by End User
- 10.3.6.5 Italy: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.5.1 Italy: Transient Protein Expression Market Breakdown, by Product Type
- 10.3.6.5.2 Italy: Transient Protein Expression Market Breakdown, by Application
- 10.3.6.5.3 Italy: Transient Protein Expression Market Breakdown, by End User
- 10.3.6.6 Spain: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.6.1 Spain: Transient Protein Expression Market Breakdown, by Product Type
- 10.3.6.6.2 Spain: Transient Protein Expression Market Breakdown, by Application
- 10.3.6.6.3 Spain: Transient Protein Expression Market Breakdown, by End User
- 10.3.6.7 Rest of Europe: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.3.6.7.1 Rest of Europe: Transient Protein Expression Market Breakdown, by Product Type
- 10.3.6.7.2 Rest of Europe: Transient Protein Expression Market Breakdown, by Application
- 10.3.6.7.3 Rest of Europe: Transient Protein Expression Market Breakdown, by End User
- 10.4 Asia Pacific
- 10.4.1 Asia Pacific Transient Protein Expression Market Overview
- 10.4.2 Asia Pacific: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.3 Asia Pacific: Transient Protein Expression Market Breakdown, by Product Type
- 10.4.3.1 Asia Pacific: Transient Protein Expression Market - Revenue and Forecast Analysis - by Product Type
- 10.4.4 Asia Pacific: Transient Protein Expression Market Breakdown, by Application
- 10.4.4.1 Asia Pacific: Transient Protein Expression Market - Revenue and Forecast Analysis - by Application
- 10.4.5 Asia Pacific: Transient Protein Expression Market Breakdown, by End User
- 10.4.5.1 Asia Pacific: Transient Protein Expression Market - Revenue and Forecast Analysis - by End User
- 10.4.6 Asia Pacific: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.4.6.1 Asia Pacific: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.4.6.2 China: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.2.1 China: Transient Protein Expression Market Breakdown, by Product Type
- 10.4.6.2.2 China: Transient Protein Expression Market Breakdown, by Application
- 10.4.6.2.3 China: Transient Protein Expression Market Breakdown, by End User
- 10.4.6.3 Japan: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.3.1 Japan: Transient Protein Expression Market Breakdown, by Product Type
- 10.4.6.3.2 Japan: Transient Protein Expression Market Breakdown, by Application
- 10.4.6.3.3 Japan: Transient Protein Expression Market Breakdown, by End User
- 10.4.6.4 India: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.4.1 India: Transient Protein Expression Market Breakdown, by Product Type
- 10.4.6.4.2 India: Transient Protein Expression Market Breakdown, by Application
- 10.4.6.4.3 India: Transient Protein Expression Market Breakdown, by End User
- 10.4.6.5 Australia: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.5.1 Australia: Transient Protein Expression Market Breakdown, by Product Type
- 10.4.6.5.2 Australia: Transient Protein Expression Market Breakdown, by Application
- 10.4.6.5.3 Australia: Transient Protein Expression Market Breakdown, by End User
- 10.4.6.6 South Korea: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.6.1 South Korea: Transient Protein Expression Market Breakdown, by Product Type
- 10.4.6.6.2 South Korea: Transient Protein Expression Market Breakdown, by Application
- 10.4.6.6.3 South Korea: Transient Protein Expression Market Breakdown, by End User
- 10.4.6.7 Rest of APAC: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.4.6.7.1 Rest of APAC: Transient Protein Expression Market Breakdown, by Product Type
- 10.4.6.7.2 Rest of APAC: Transient Protein Expression Market Breakdown, by Application
- 10.4.6.7.3 Rest of APAC: Transient Protein Expression Market Breakdown, by End User
- 10.5 South and Central America
- 10.5.1 South and Central America Transient Protein Expression Market Overview
- 10.5.2 South and Central America: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.3 South and Central America: Transient Protein Expression Market Breakdown, by Product Type
- 10.5.3.1 South and Central America: Transient Protein Expression Market - Revenue and Forecast Analysis - by Product Type
- 10.5.4 South and Central America: Transient Protein Expression Market Breakdown, by Application
- 10.5.4.1 South and Central America: Transient Protein Expression Market - Revenue and Forecast Analysis - by Application
- 10.5.5 South and Central America: Transient Protein Expression Market Breakdown, by End User
- 10.5.5.1 South and Central America: Transient Protein Expression Market - Revenue and Forecast Analysis - by End User
- 10.5.6 South and Central America: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.5.6.1 South and Central America: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.5.6.2 Brazil: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.6.2.1 Brazil: Transient Protein Expression Market Breakdown, by Product Type
- 10.5.6.2.2 Brazil: Transient Protein Expression Market Breakdown, by Application
- 10.5.6.2.3 Brazil: Transient Protein Expression Market Breakdown, by End User
- 10.5.6.3 Argentina: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.6.3.1 Argentina: Transient Protein Expression Market Breakdown, by Product Type
- 10.5.6.3.2 Argentina: Transient Protein Expression Market Breakdown, by Application
- 10.5.6.3.3 Argentina: Transient Protein Expression Market Breakdown, by End User
- 10.5.6.4 Rest of South and Central America: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.5.6.4.1 Rest of South and Central America: Transient Protein Expression Market Breakdown, by Product Type
- 10.5.6.4.2 Rest of South and Central America: Transient Protein Expression Market Breakdown, by Application
- 10.5.6.4.3 Rest of South and Central America: Transient Protein Expression Market Breakdown, by End User
- 10.6 Middle East and Africa
- 10.6.1 Middle East and Africa Transient Protein Expression Market Overview
- 10.6.2 Middle East and Africa: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.3 Middle East and Africa: Transient Protein Expression Market Breakdown, by Product Type
- 10.6.3.1 Middle East and Africa: Transient Protein Expression Market - Revenue and Forecast Analysis - by Product Type
- 10.6.4 Middle East and Africa: Transient Protein Expression Market Breakdown, by Application
- 10.6.4.1 Middle East and Africa: Transient Protein Expression Market - Revenue and Forecast Analysis - by Application
- 10.6.5 Middle East and Africa: Transient Protein Expression Market Breakdown, by End User
- 10.6.5.1 Middle East and Africa: Transient Protein Expression Market - Revenue and Forecast Analysis - by End User
- 10.6.6 Middle East and Africa: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.6.6.1 Middle East and Africa: Transient Protein Expression Market - Revenue and Forecast Analysis - by Country
- 10.6.6.2 Saudi Arabia: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.6.2.1 Saudi Arabia: Transient Protein Expression Market Breakdown, by Product Type
- 10.6.6.2.2 Saudi Arabia: Transient Protein Expression Market Breakdown, by Application
- 10.6.6.2.3 Saudi Arabia: Transient Protein Expression Market Breakdown, by End User
- 10.6.6.3 South Africa: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.6.3.1 South Africa: Transient Protein Expression Market Breakdown, by Product Type
- 10.6.6.3.2 South Africa: Transient Protein Expression Market Breakdown, by Application
- 10.6.6.3.3 South Africa: Transient Protein Expression Market Breakdown, by End User
- 10.6.6.4 United Arab Emirates: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.6.4.1 United Arab Emirates: Transient Protein Expression Market Breakdown, by Product Type
- 10.6.6.4.2 United Arab Emirates: Transient Protein Expression Market Breakdown, by Application
- 10.6.6.4.3 United Arab Emirates: Transient Protein Expression Market Breakdown, by End User
- 10.6.6.5 Rest of Middle East and Africa: Transient Protein Expression Market - Revenue and Forecast to 2031 (US$ Million)
- 10.6.6.5.1 Rest of Middle East and Africa: Transient Protein Expression Market Breakdown, by Product Type
- 10.6.6.5.2 Rest of Middle East and Africa: Transient Protein Expression Market Breakdown, by Application
- 10.6.6.5.3 Rest of Middle East and Africa: Transient Protein Expression Market Breakdown, by End User
11. Competitive Landscape
- 11.1 Company Positioning & Concentration
12. Industry Landscape
- 12.1 Overview
- 12.2 Growth Strategies in Transient Protein Expression Market
- 12.3 Organic Growth Strategies
- 12.3.1 Overview
- 12.4 Inorganic Growth Strategies
- 12.4.1 Overview
13. Company Profiles
- 13.1 Thermo Fisher Scientific Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
- 13.2 Merck KGaA
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
- 13.3 QIAGEN NV
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
- 13.4 GenScript Biotech Corporation
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
- 13.5 Promega Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
- 13.6 Takara Bio Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
- 13.7 New England Biolabs
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
- 13.8 Agilent Technologies Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
- 13.9 Mirus Bio LLC
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
- 13.10 Bio-Rad Laboratories Inc
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
- 13.11 Lonza Group AG
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
- 13.12 MaxCyte Inc
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
14. Appendix
- 14.1 About The Insight Partners
- 14.2 Glossary of Terms
